Evidence map›Paper›PMID 33841675›Full record

ArticleAmerican journal of translational research2021

miR-30a-5p targets Becn1 to ameliorate high-glucose-induced glomerular podocyte injury in immortalized rat podocyte cell line.

Xiu Yang, Ming Yang, Yuemei Chen, Yingying Qian, Xiao Fei, Chanjuan Gong, Ming Wang, Xiangcheng Xie, Zhen Wang

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xiu YangDepartment of Nephrology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang Province, China.
Ming YangDepartment of Nephrology, Shanghai Changzheng Hospital Shanghai City, China.
Yuemei ChenDepartment of Nephrology, The Second Affiliated School of Medicine, Hospital of Zhejiang University Hangzhou, Zhejiang Province, China.
Yingying QianDepartment of Nephrology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang Province, China.
Xiao FeiDepartment of Nephrology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang Province, China.
Chanjuan GongDepartment of Nephrology, Shanghai Changzheng Hospital Shanghai City, China.
Ming WangDepartment of Nephrology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang Province, China.
Xiangcheng XieDepartment of Nephrology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang Province, China.
Zhen WangDepartment of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine Shanghai, China.
Shanghai Tenth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDiabetic nephropathy (DN) is a serious kidney-based complication of diabetes, wherein podocyte injury is deemed crucial in the development of early stage. Various miRNAs, as report goes, is involved in the pathogenesis of varieties of kidney diseases including DN. In this study, we found a target relationship between miR-30a-5p and Becn1, of which there are few studies about the role in podocyte injury. We therefore used immortalized rat podocyte cell line to explore the role and molecular mechanism of miR-30a-5p targeting Becn1 gene in high-glucose-induced glomerular podocyte injury.

methodsThe mRNA and protein expressions of miR-30a-5p and Becn1 were detected respectively by quantitative reverse transcriptase PCR and western blotting. The proliferation, apoptosis, and the levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-α were detected by MTT assay, flow cytometry, and enzyme-linked immuno sorbent assay, respectively. Intracellular reactive oxygen species (ROS), superoxide dismutase (SOD) and malondialdehyde (MDA) levels were also determined.

resultsCompared with normal group, miR-30a-5p in model groups were down-regulated, while Becn1 expression was significantly up-regulated, with slower proliferation, higher apoptosis rate, lower SOD level, and significantly higher ROS, MDA, IL-6, and TNF-α levels (all P<0.05). Overexpression of miR-30a-5p or Becn1 knock-out could lower Becn1 expression, apoptosis rate, promote proliferation, with relatively higher SOD level and lower ROS, MDA, Il-6, and TNF-α levels of model cells (all P<0.05).

conclusionUp-regulation of miR-30a-5p can suppress the expression of Becn1 to increase the growth and inhibit the apoptosis of immortalized rat podocyte cell line, therefore ameliorating podocyte injury induced by high glucose in vitro.

Indexed as

apoptosisBecn1miR-30a-5pPodocyteproliferation

Identifiers

PMID33841675
PMCPMC8014343
OpenAlexW3155153314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.